Novo’s main Ozempic plant cited for quality lapses by FDA

  • Posted on October 29, 2024
  • By Fortune
  • 1 Views
Novo’s main Ozempic plant cited for quality lapses by FDA

Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.
continue reading...

Author
Fortune

You May Also Like